Polo‐like kinase 1 (PLK1), encoded by the PLK1 gene and mainly consisting of a Pkinase domain and two Polo‐box domains (PB1 and PB2),1 is generally considered as a cancer promoter, owing to its critical role in cell cycle and overexpression.2 This evidence concerns the gene PLK1 and cancer.